199 related articles for article (PubMed ID: 20099342)
1. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis.
Han J; Ma L
J Magn Reson Imaging; 2010 Feb; 31(2):305-8. PubMed ID: 20099342
[TBL] [Abstract][Full Text] [Related]
2. Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis.
Lombardo F; Frijia F; Bongioanni P; Canapicchi R; Minichilli F; Bianchi F; Hlavata H; Rossi B; Montanaro D
Arch Ital Biol; 2009 Sep; 147(3):69-82. PubMed ID: 20014653
[TBL] [Abstract][Full Text] [Related]
3. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia.
Sarac H; Zagar M; Vranjes D; Henigsberg N; Bilić E; Pavlisa G
Coll Antropol; 2008 Jan; 32 Suppl 1():205-10. PubMed ID: 18405084
[TBL] [Abstract][Full Text] [Related]
5. MR spectroscopy evaluation and short-term outcome of olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients.
Huang H; Tan K; Chen L; Xue Y; Wang H; Xi H; Liu Y; Zhang F; Zhang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jan; 21(1):52-7. PubMed ID: 17305006
[TBL] [Abstract][Full Text] [Related]
6. Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis.
Pyra T; Hui B; Hanstock C; Concha L; Wong JC; Beaulieu C; Johnston W; Kalra S
Amyotroph Lateral Scler; 2010; 11(1-2):157-65. PubMed ID: 19242831
[TBL] [Abstract][Full Text] [Related]
7. ALS surrogate markers. MRS.
Kalra S; Arnold DL
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():111-4. PubMed ID: 15512889
[TBL] [Abstract][Full Text] [Related]
8. Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy.
Weerasekera A; Peeters R; Sima D; Dresselaers T; Sunaert S; De Vocht J; Claeys K; Van Huffel S; Van Damme P; Himmelreich U
Brain Res; 2019 Sep; 1718():22-31. PubMed ID: 31002818
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cervical cord 1H-magnetic resonance spectroscopy and clinoco-electromyographic profile in amyotrophic lateral sclerosis.
Ikeda K; Murata K; Kawase Y; Kawabe K; Kano O; Yoshii Y; Takazawa T; Hirayama T; Iwasaki Y
Muscle Nerve; 2013 Jan; 47(1):61-7. PubMed ID: 23042532
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T.
Wang S; Poptani H; Woo JH; Desiderio LM; Elman LB; McCluskey LF; Krejza J; Melhem ER
Radiology; 2006 Jun; 239(3):831-8. PubMed ID: 16641339
[TBL] [Abstract][Full Text] [Related]
11. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
[TBL] [Abstract][Full Text] [Related]
12. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.
Liu C; Jiang R; Yi X; Zhu W; Bu B
J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526
[TBL] [Abstract][Full Text] [Related]
13. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis.
Atassi N; Xu M; Triantafyllou C; Keil B; Lawson R; Cernasov P; Ratti E; Long CJ; Paganoni S; Murphy A; Salibi N; Seethamraju R; Rosen B; Ratai EM
PLoS One; 2017; 12(5):e0177680. PubMed ID: 28498852
[TBL] [Abstract][Full Text] [Related]
14. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
15. Integrated imaging of [
Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
17. Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study.
Lucetti C; Del Dotto P; Gambaccini G; Ceravolo R; Logi C; Berti C; Rossi G; Bianchi MC; Tosetti M; Murri L; Bonuccelli U
Mov Disord; 2007 Nov; 22(15):2170-5. PubMed ID: 17722082
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy (1H-MRS) reveals the presence of elevated myo-inositol in the occipital cortex of blind subjects.
Bernabeu A; Alfaro A; García M; Fernández E
Neuroimage; 2009 Oct; 47(4):1172-6. PubMed ID: 19426816
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of cerebral metabolism by multi-voxel proton magnetic resonance spectroscopy imaging in chronic unilateral internal carotid artery occlusion].
Takayama H; Suga S; Kobayashi M; Sadanaga F; Hozumi A; Kanai Y; Okamura M; Mihara B
No To Shinkei; 2000 Apr; 52(4):307-12. PubMed ID: 10793417
[TBL] [Abstract][Full Text] [Related]
20. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW
Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]